Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2010 (2010), Article ID 537263, 8 pages
http://dx.doi.org/10.1155/2010/537263
Review Article

Toll-Like Receptors in Hepatic Ischemia/Reperfusion and Transplantation

Department of Surgery, University of Pittsburgh School of Medicine, 200 Lothrop St., Pittsburgh, PA 15213, USA

Received 28 April 2010; Accepted 8 July 2010

Academic Editor: Ekihiro Seki

Copyright © 2010 John Evankovich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Katsargyris, C. Klonaris, A. Alexandrou, A. E. Giakoustidis, I. Vasileiou, and S. Theocharis, “Toll like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation?” Expert Opinion on Therapeutic Targets, vol. 13, no. 4, pp. 427–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Lemaitre, E. Nicolas, L. Michaut, J.-M. Reichhart, and J. A. Hoffmann, “The dorsoventral regulatory gene cassette spatzle/Toll/Cactus controls the potent antifungal response in Drosophila adults,” Cell, vol. 86, no. 6, pp. 973–983, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway Jr., “A human homologue of the Drosophila toll protein signals activation of adaptive immunity,” Nature, vol. 388, no. 6640, pp. 394–397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Beutler, “The Toll-like receptors: analysis by forward genetic methods,” Immunogenetics, vol. 57, no. 6, pp. 385–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Beutler, “Inferences, questions and possibilities in Toll-like receptor signalling,” Nature, vol. 430, no. 6996, pp. 257–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. A. J. O'Neill and A. G. Bowie, “The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling,” Nature Reviews Immunology, vol. 7, no. 5, pp. 353–364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Liu, D. J. Gallo, A. M. Green et al., “Role of Toll-like receptors in changes in gene expression and NF-κB activation in mouse hepatocytes stimulated with lipopolysaccharide,” Infection and Immunity, vol. 70, no. 7, pp. 3433–3442, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Knolle, J. Schlaak, A. Uhrig, P. Kempf, K.-H. Meyer zum Buschenfelde, and G. Gerken, “Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge,” Journal of Hepatology, vol. 22, no. 2, pp. 226–229, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Tu, A. Bozorgzadeh, R. H. Pierce, J. Kurtis, I. N. Crispe, and M. S. Orloff, “TLR-dependent cross talk between human Kupffer cells and NK cells,” Journal of Experimental Medicine, vol. 205, no. 1, pp. 233–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. I. N. Crispe, “The liver as a lymphoid organ,” Annual Review of Immunology, vol. 27, pp. 147–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Seki and D. A. Brenner, “Toll-like receptors and adaptor molecules in liver disease: update,” Hepatology, vol. 48, no. 1, pp. 322–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Katsargyris, C. Klonaris, A. Alexandrou, A. E. Giakoustidis, I. Vasileiou, and S. Theocharis, “Toll like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation?” Expert Opinion on Therapeutic Targets, vol. 13, no. 4, pp. 427–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Jaeschke, A. Farhood, and C. W. Smith, “Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo,” FASEB Journal, vol. 4, no. 15, pp. 3355–3359, 1990. View at Google Scholar · View at Scopus
  14. H. Jaeschke, C. V. Smith, and J. R. Mitchell, “Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver,” Journal of Clinical Investigation, vol. 81, no. 4, pp. 1240–1246, 1988. View at Google Scholar · View at Scopus
  15. H. Jaeschke, C. V. Smith, and J. R. Mitchell, “Hypoxic damage generates reactive oxygen species in isolated perfused rat liver,” Biochemical and Biophysical Research Communications, vol. 150, no. 2, pp. 568–574, 1988. View at Google Scholar · View at Scopus
  16. G. A. Wanner, W. Ertel, P. Müller et al., “Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation,” Shock, vol. 5, no. 1, pp. 34–40, 1996. View at Google Scholar · View at Scopus
  17. N. Shirasugi, G. Wakabayashi, M. Shimazu et al., “Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury,” Transplantation, vol. 64, no. 10, pp. 1398–1403, 1997. View at Google Scholar · View at Scopus
  18. M. L. Bajt, A. Farhood, and H. Jaeschke, “Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature,” American Journal of Physiology, vol. 281, no. 5, pp. G1188–G1195, 2001. View at Google Scholar · View at Scopus
  19. R. Witthaut, A. Farhood, C. W. Smith, and H. Jaeschke, “Complement and tumor necrosis factor-α contribute to Mac-1 (CD11b/CD18) up-regulation and systemic neutrophil activation during endotoxemia in vivo,” Journal of Leukocyte Biology, vol. 55, no. 1, pp. 105–111, 1994. View at Google Scholar · View at Scopus
  20. R. M. Zwacka, Y. Zhang, J. Halldorson, H. Schlossberg, L. Dudus, and J. F. Engelhardt, “CD4+ T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver,” Journal of Clinical Investigation, vol. 100, no. 2, pp. 279–289, 1997. View at Google Scholar · View at Scopus
  21. L. M. Colletti, S. L. Kunkel, A. Walz et al., “Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein,” Journal of Clinical Investigation, vol. 95, no. 1, pp. 134–141, 1995. View at Google Scholar · View at Scopus
  22. A. B. Lentsch, H. Yoshidome, W. G. Cheadle, F. N. Miller, and M. J. Edwards, “Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC,” Hepatology, vol. 27, no. 4, pp. 1172–1177, 1998. View at Publisher · View at Google Scholar
  23. A. D. Luster, “Mechanisms of disease: chemokines—chemotactic cytokines that mediate inflammation,” The New England Journal of Medicine, vol. 338, no. 7, pp. 436–445, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Caldwell-Kenkel, R. T. Currin, Y. Tanaka, R. G. Thurman, and J. J. Lemasters, “Reperfusion injury to endothelial cells following cold ischemic storage of rat livers,” Hepatology, vol. 10, no. 3, pp. 292–299, 1989. View at Google Scholar · View at Scopus
  25. J. C. Caldwell-Kenkel, R. T. Currin, Y. Tanaka, R. G. Thurman, and J. J. Lemasters, “Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion,” Hepatology, vol. 13, no. 1, pp. 83–95, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Ohashi, V. Burkart, S. Flohé, and H. Kolb, “Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex,” Journal of Immunology, vol. 164, no. 2, pp. 558–561, 2000. View at Google Scholar · View at Scopus
  27. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Gill, A. Tsung, and T. Billiar, “Linking oxidative stress to inflammation: Toll-like receptors,” Free Radical Biology and Medicine, vol. 48, no. 9, pp. 1121–1132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-S. Wu, J.-X. Zhang, L. Wang, Y. Tian, H. Wang, and O. Rotstein, “Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice,” Hepatobiliary and Pancreatic Diseases International, vol. 3, no. 2, pp. 250–253, 2004. View at Google Scholar · View at Scopus
  30. Y. Zhai, X.-D. Shen, R. O'Connell et al., “Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway,” Journal of Immunology, vol. 173, no. 12, pp. 7115–7119, 2004. View at Google Scholar · View at Scopus
  31. X.-D. Shen, B. Ke, Y. Zhai et al., “Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury,” American Journal of Transplantation, vol. 5, no. 8, pp. 1793–1800, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Tsung, R. Sahai, H. Tanaka et al., “The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion,” Journal of Experimental Medicine, vol. 201, no. 7, pp. 1135–1143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Tsung, R. A. Hoffman, K. Izuishi et al., “Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells,” Journal of Immunology, vol. 175, no. 11, pp. 7661–7668, 2005. View at Google Scholar · View at Scopus
  34. J. M. Prince, R. M. Levy, R. Yang et al., “Toll-Like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock,” Journal of the American College of Surgeons, vol. 202, no. 3, pp. 407–417, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Tsung, J. R. Klune, X. Zhang et al., “HMGB1 release induced by liver ischemia involves Toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling,” Journal of Experimental Medicine, vol. 204, no. 12, pp. 2913–2923, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Tsung, R. A. Hoffman, K. Izuishi et al., “Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells,” Journal of Immunology, vol. 175, no. 11, pp. 7661–7668, 2005. View at Google Scholar · View at Scopus
  37. A. Tsung, N. Zheng, G. Jeyabalan et al., “Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 119–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Hui, Z. Jinxiang, W. Heshui, L. Zhuoya, and Z. Qichang, “Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury,” Biochemical and Biophysical Research Communications, vol. 389, no. 2, pp. 328–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Zhai, X.-D. Shen, R. O'Connell et al., “Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway,” Journal of Immunology, vol. 173, no. 12, pp. 7115–7119, 2004. View at Google Scholar · View at Scopus
  40. Y. Zhai, B. Qiao, F. Gao et al., “Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion,” Hepatology, vol. 47, no. 1, pp. 199–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Zhai, X.-D. Shen, F. Gao et al., “CXCL10 regulates liver innate immune response against ischemia and reperfusion injury,” Hepatology, vol. 47, no. 1, pp. 207–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Negishi, Y. Fujita, H. Yanai et al., “Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 41, pp. 15136–15141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Tsung, M. T. Stang, A. Ikeda et al., “The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury,” American Journal of Physiology, vol. 290, no. 6, pp. G1261–G1268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. K.-H. Kim, R. Dhupar, S. Ueki et al., “Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury,” Surgery, vol. 146, no. 2, pp. 181–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Ueki, R. Dhupar, J. Cardinal et al., “Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury,” Hepatology, vol. 51, no. 5, pp. 1692–1701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Tsoulfas, Y. Takahashi, R. W. Ganster et al., “Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury,” Transplantation, vol. 74, no. 1, pp. 7–13, 2002. View at Google Scholar · View at Scopus
  47. X.-D. Shen, B. Ke, Y. Zhai et al., “Absence of Toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model,” Liver Transplantation, vol. 13, no. 10, pp. 1435–1443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-F. Deng, L. Geng, Y.-G. Qian et al., “The role of Toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation,” Transplantation Proceedings, vol. 39, no. 10, pp. 3222–3224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Shishido, N. Nozaki, S. Yamaguchi et al., “Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction,” Circulation, vol. 108, no. 23, pp. 2905–2910, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Favre, P. Musette, V. Douin-Echinard et al., “Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 5, pp. 1064–1071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. A. A. Shigeoka, T. D. Holscher, A. J. King et al., “TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both myD88-dependent and -independent pathways,” Journal of Immunology, vol. 178, no. 10, pp. 6252–6258, 2007. View at Google Scholar · View at Scopus
  52. J. C. Leemans, G. Stokman, N. Claessen et al., “Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney,” Journal of Clinical Investigation, vol. 115, no. 10, pp. 2894–2903, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. S.-C. Tang, T. V. Arumugam, X. Xu et al., “Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13798–13803, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Ziegler, D. Harhausen, C. Schepers et al., “TLR2 has a detrimental role in mouse transient focal cerebral ischemia,” Biochemical and Biophysical Research Communications, vol. 359, no. 3, pp. 574–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Lehnardt, S. Lehmann, D. Kaul et al., “Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia,” Journal of Neuroimmunology, vol. 190, no. 1-2, pp. 28–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. C. J. Aprahamian, R. G. Lorenz, C. M. Harmon, and R. A. Dimmit, “Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model,” Pediatric Critical Care Medicine, vol. 9, no. 1, pp. 105–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Hemmi, O. Takeuchi, T. Kawai et al., “A Toll-like receptor recognizes bacterial DNA,” Nature, vol. 408, no. 6813, pp. 740–745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Yasuda, P. Yu, C. J. Kirschning et al., “Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways,” Journal of Immunology, vol. 174, no. 10, pp. 6129–6136, 2005. View at Google Scholar · View at Scopus
  59. K. Yasuda, M. Rutz, B. Schlatter et al., “CpG motif-independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA,” European Journal of Immunology, vol. 36, no. 2, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. F. J. Barrat, T. Meeker, J. Gregorio et al., “Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus,” Journal of Experimental Medicine, vol. 202, no. 8, pp. 1131–1139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Haas, J. Metzger, F. Schmitz et al., “The DNA sugar backbone 2 deoxyribose determines Toll-like receptor 9 activation,” Immunity, vol. 28, no. 3, pp. 315–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. Z. M. Bamboat, V. P. Balachandran, L. M. Ocuin, H. Obaid, G. Plitas, and R. P. DeMatteo, “Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury,” Hepatology, vol. 51, no. 2, pp. 621–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. Z. M. Bamboat, L. M. Ocuin, V. P. Balachandran, H. Obaid, G. Plitas, and R. P. DeMatteo, “Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion,” Journal of Clinical Investigation, vol. 120, no. 2, pp. 559–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Jomantaite, N. Dikopoulos, A. Kröger et al., “Hepatic dendritic cell subsets in the mouse,” European Journal of Immunology, vol. 34, no. 2, pp. 355–365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Muhanna, S. Doron, O. Wald et al., “Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis,” Hepatology, vol. 48, no. 3, pp. 963–977, 2008. View at Publisher · View at Google Scholar · View at Scopus